3-methoxytyramine has been researched along with BH4 Deficiency in 1 studies
3-methoxytyramine: RN given refers to parent cpd
3-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Puglisi-Allegra, S | 1 |
| Cabib, S | 1 |
| Pascucci, T | 1 |
| Ventura, R | 1 |
| Cali, F | 1 |
| Romano, V | 1 |
1 other study available for 3-methoxytyramine and BH4 Deficiency
| Article | Year |
|---|---|
Dramatic brain aminergic deficit in a genetic mouse model of phenylketonuria.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amygdala; Animals; Biogenic Monoamines; Brain; Caudate Nucleus; Dise | 2000 |